serine/threonine Kinase 17b (STK17B) (C-Term) Peptide
STK17B
适用: 人
BP
Sodium azide
-
-
抗原
See all DRAK2 (STK17B) products
-
DRAK2 (STK17B)
(serine/threonine Kinase 17b (STK17B))
-
蛋白结构域
-
C-Term
-
宿主
-
人
-
应用范围
-
Blocking Peptide (BP)
-
产品特性
-
15 amino acids near the carboxy terminus of human DRAK2.
Human
-
-
-
应用备注
-
DRAK2 peptide is used for blocking the activity of DRAK2.
-
限制
-
仅限研究用
-
-
状态
-
Liquid
-
浓度
-
200 μg/mL
-
缓冲液
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
储存液
-
Sodium azide
-
注意事项
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
-
-20 °C
-
有效期
-
12 months
-
-
抗原
-
DRAK2 (STK17B)
(serine/threonine Kinase 17b (STK17B))
-
别名
-
zgc:65989 Peptide, STK17B Peptide, DRAK2 Peptide, Drak2 Peptide, 3110009A03Rik Peptide, AI120141 Peptide, serine/threonine kinase 17b (apoptosis-inducing) Peptide, serine/threonine kinase 17b Peptide, stk17b Peptide, STK17B Peptide, Stk17b Peptide
-
You are here:
-
首页
-
多肽
-
DRAK2
-
serine/threonine Kinase 17b (STK17B) (C-Term) Peptide (ABIN1382031)